杜氏肌营养不良
mdx鼠标
肌营养不良蛋白
医学
溶酶体
遗传增强
下调和上调
肌营养不良
生物信息学
临床试验
溶酶体贮存病
肌病
变性(医学)
骨骼肌
病态的
自噬
疾病
机制(生物学)
转录组
治疗方法
心肌细胞
外显子跳跃
酶替代疗法
肌肉疾病
肌肉无力
神经科学
癌症研究
治疗效果
病毒载体
内科学
作者
Abbass Jaber,Luigi Palmieri,Rania Bakour,Elise Lachiver,Ai Vu Hong,Nathalie Bourg,J. Pupiot,Jérôme Poupiot,D. Stokholm,Laetitia van Wittenberghe,Laetitia Van Wittenberghe,Adeline Miranda,Inès Barthélémy,Nathalie Danièle,Inès Barthélémy,Stéphane Blot,Mai Thao Bui,Bornale Das,Edoardo Malfatti,Teresinha Evangelista
出处
期刊:Science Advances
[American Association for the Advancement of Science]
日期:2025-09-01
卷期号:11 (43): 105633-105633
被引量:14
标识
DOI:10.1126/sciadv.adv6805
摘要
Duchenne muscular dystrophy (DMD), a muscle degenerative disease affecting young boys, arises from the loss of dystrophin. Current gene therapy approaches aim to restore a shortened form of dystrophin (microdystrophin) via adeno-associated vector delivery. While recent clinical studies show promise, therapeutic efficacy remains incomplete, emphasizing the need for improved approaches. Here, we identified lysosomal perturbations in myofibers of patients with DMD and animal models, an overlooked mechanism of cellular damage in muscular dystrophies. These were notably marked by the up-regulation and recruitment of Galectin-3, a biomarker of lysosomal membrane permeabilization, to lysosomes, alongside alterations in lysosome number, morphology, and function. Microdystrophin therapy in Dmd mdx mice fails to fully correct these damages. However, combining it with trehalose, a lysosome-protective disaccharide, substantially improves the outcome, enhancing muscle function, myopathology, and transcriptome. These findings highlight lysosomal damage as an important pathomechanism in DMD and suggest that combining trehalose with gene therapy could enhance therapeutic efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI